|
| |
| | | 69049 | | 30.10.2023 | | Janssen-Cilag AG | | | | | | | 31.12.2026 | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Talvey 3 mg/1.5 ml | Injektionslösung | Injection solution (Talquetamabum 3mg / 1.5ml) | L01FX29 | | | 02 | Talvey 40 mg/1.0 ml | Injektionslösung | Injection solution (Talquetamabum 40 mg/ml) | L01FX29 | | | 03 | Talvey | | (Talquetamabum 3 mg) | L01FX29 | | | 04 | Talvey | | (Talquetamabum 40 mg) | L01FX29 | |
|
|
|
